Mesoblast Ltd. (MESO)
Mesoblast Market Cap: 2.233B for Jan. 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Telix Pharmaceuticals Ltd. | 2.597B |
| Alterity Therapeutics Ltd. | 62.53M |
| Kazia Therapeutics Ltd. | 81.17M |
| Immutep Ltd. | 427.94M |
| Propanc Biopharma, Inc. | 4.190M |
Market Cap Related Metrics
| PS Ratio | 122.47 |
| Price to Book Value | 4.449 |
| Price | 17.45 |
| Earnings Yield | -4.85% |